Literature DB >> 2065420

The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases.

J F Hardy1, J Perrault, N Tremblay, D Robitaille, R Blain, M Carrier.   

Abstract

The use of blood products in 1480 consecutive cases of adult cardiac surgical procedures over a period of 15 mth was studied retrospectively using the database of the Department of Anaesthesia of the Institut de Cardiologie de Montréal. Use of blood products was compared in patients having (1) coronary artery bypass grafting, (2) valvular surgery, (3) or a combination of 1 and 2. First operations were compared with reoperations. Overall, the use of homologous blood products was greatest in patients of Group 3, intermediate in patients of Group 2, and smallest in patients of Group 1. Reoperations were associated with an increase in intraoperative transfusion of packed red blood cells, but postoperative chest drainage was similar to first operations. When all blood products (packed red blood cells, fresh frozen plasma and platelets) were taken into consideration, patients undergoing primary CABG or valve surgery were the least exposed to homologous blood donors (five and six units transfused respectively). Repeat CABG was associated with an intermediate exposure to homologous blood products (eight units). Finally, primary and repeat combined procedures, and repeat valve surgery were associated with the greatest exposure to foreign blood products (10, 13 and 10 units respectively). The data presented in this study provide a rational basis for stratification of procedures according to the expected use of blood products, particularly in view of future studies which may be planned to examine the efficiency of blood conservation strategies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065420     DOI: 10.1007/BF03007591

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  16 in total

1.  50th Anniversary Landmark Commentary on Cosgrove DM, Thurer RL, Lytle BW, Gill CG, Peter M, Loop FD. Blood conservation during myocardial revascularization. Ann Thorac Surg 1979;28:184-9.

Authors:  Lars G Svensson
Journal:  Ann Thorac Surg       Date:  2015-08       Impact factor: 4.330

2.  Prophylactic treatment of postperfusion bleeding using EACA.

Authors:  A J DelRossi; A C Cernaianu; S Botros; G M Lemole; R Moore
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

3.  Autotransfusion following cardiac operations: a randomized, prospective study.

Authors:  R L Thurer; B W Lytle; D M Cosgrove; F D Loop
Journal:  Ann Thorac Surg       Date:  1979-06       Impact factor: 4.330

4.  Open-heart surgery and the demand for blood.

Authors:  J K Roche; J M Stengle
Journal:  JAMA       Date:  1973-09-17       Impact factor: 56.272

5.  Transfusion of predonated autologous blood in elective cardiac surgery.

Authors:  T R Love; W G Hendren; D D O'Keefe; W M Daggett
Journal:  Ann Thorac Surg       Date:  1987-05       Impact factor: 4.330

6.  Blood loss and bank blood requirement in coronary bypass surgery.

Authors:  T Yeh; L Shelton; T J Yeh
Journal:  Ann Thorac Surg       Date:  1978-07       Impact factor: 4.330

7.  The efficacy of postoperative autotransfusion in patients undergoing cardiac operations.

Authors:  R G Johnson; K R Rosenkrantz; R A Preston; C Hopkins; W M Daggett
Journal:  Ann Thorac Surg       Date:  1983-08       Impact factor: 4.330

8.  Determinants of blood utilization during myocardial revascularization.

Authors:  D M Cosgrove; F D Loop; B W Lytle; C C Gill; L R Golding; P C Taylor; S B Forsythe
Journal:  Ann Thorac Surg       Date:  1985-10       Impact factor: 4.330

9.  Reduction of blood usage in open heart surgery.

Authors:  A J Tector; R P Gabriel; W E Matericka; S S Oparah; R J Flemma; D Lepley
Journal:  Chest       Date:  1976-10       Impact factor: 9.410

10.  Autotransfusion of shed mediastinal blood after cardiac surgery: a prospective study.

Authors:  H V Schaff; J M Hauer; W R Bell; T J Gardner; J S Donahoo; V L Gott; R K Brawley
Journal:  J Thorac Cardiovasc Surg       Date:  1978-04       Impact factor: 5.209

View more
  9 in total

Review 1.  Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.

Authors:  J F Hardy; S Bélisle
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

2.  Cardiac surgical patients must not be denied the benefits of autologous blood predonation.

Authors:  J F Hardy; S Bélisle; F Décary
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

3.  Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.

Authors:  J F Hardy; J Desroches; S Belisle; J Perrault; M Carrier; D Robitaille
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

Review 4.  Natural and synthetic antifibrinolytics in cardiac surgery.

Authors:  J F Hardy; J Desroches
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

5.  The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.

Authors:  Yihong Xie; Sheliang Shen; Jun Zhang; Wenyuan Wang; Jiayin Zheng
Journal:  Int J Med Sci       Date:  2015-04-01       Impact factor: 3.738

6.  Why does a point of care guided transfusion algorithm not improve blood loss and transfusion practice in patients undergoing high-risk cardiac surgery? A prospective randomized controlled pilot study.

Authors:  F Lehmann; J Rau; B Malcolm; M Sander; C von Heymann; T Moormann; T Geyer; F Balzer; K D Wernecke; L Kaufner
Journal:  BMC Anesthesiol       Date:  2019-02-18       Impact factor: 2.217

7.  Intraoperative bispectral index monitoring and time to extubation after cardiac surgery: secondary analysis of a randomized controlled trial.

Authors:  Jennifer L Vance; Amy M Shanks; Derek T Woodrum
Journal:  BMC Anesthesiol       Date:  2014-09-18       Impact factor: 2.217

8.  Effects of Cardiopulmonary Bypass on Mediastinal Drainage and the Use of Blood Products in the Intensive Care Unit in 60- to 80-Year-Old Patients Who Have Undergone Coronary Artery Bypass Grafting.

Authors:  Fatih Aygün; Mehmet Özülkü; Murat Günday
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

9.  The effect of non-point-of-care haemostasis management protocol implementation in cardiac surgery: A systematic review.

Authors:  Reinier P J Boxma; Robert P Garnier; Carolien S E Bulte; Michael I Meesters
Journal:  Transfus Med       Date:  2021-06-06       Impact factor: 2.019

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.